About
Technology
Issues
FAQ
Links
Official Page
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.